Armstrong C P, Blower A L
Gut. 1987 May;28(5):527-32. doi: 10.1136/gut.28.5.527.
Two hundred and thirty five consecutive patients with a life threatening complication of peptic ulceration, who either died or required emergency surgery, have been studied over a 36 month period. Seventy eight of these high risk patients died; 25 at home, 19 in hospital without surgery and 34 postoperatively. Ninety eight patients had bleeding ulcers, 132 perforated ulcers and five had both bleeding and perforated ulcers. One hundred and forty one of these 235 patients (60%) were taking a non-steroidal anti-inflammatory drugs (NSAID) and the individual agents have been listed. The overall incidence of NSAID use in a hospital control group was 9.9%. The first sign of an ulcer was a life threatening complication in 58.2% of patients taking a NSAID. Nearly 80% of all ulcer related deaths occurred in patients using an anti-inflammatory agent. Patients using these drugs were older, with more pre-existing medical conditions and had larger ulcers than those not taking NSAIDs. The mortality associated with a peptic ulcer complication in patients taking a NSAID was more than twice that in patients with no such drug history. There appears to be a relationship between the development of a life threatening complication of peptic ulceration and NSAID ingestion. Much of the associated mortality and morbidity may be potentially avoidable.
在36个月的时间里,对连续235例患有危及生命的消化性溃疡并发症(死亡或需要急诊手术)的患者进行了研究。这些高危患者中有78例死亡,25例在家中死亡,19例在未进行手术的情况下于医院死亡,34例术后死亡。98例患者为出血性溃疡,132例为穿孔性溃疡,5例同时有出血和穿孔性溃疡。这235例患者中有141例(60%)正在服用非甾体抗炎药(NSAID),具体药物已列出。医院对照组中NSAID的总体使用率为9.9%。在服用NSAID的患者中,58.2%的患者溃疡的首发症状是危及生命的并发症。几乎所有与溃疡相关的死亡病例中有80%发生在使用抗炎药的患者中。使用这些药物的患者年龄更大,有更多的基础疾病,溃疡也比未服用NSAID的患者更大。服用NSAID的患者消化性溃疡并发症相关的死亡率是无此类用药史患者的两倍多。消化性溃疡危及生命的并发症的发生与服用NSAID之间似乎存在关联。许多相关的死亡率和发病率可能是可以避免的。